Synonym
Glibenclamide sodium; Glyburide sodium
IUPAC/Chemical Name
sodium ((4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenyl)sulfonyl)(cyclohexylcarbamoyl)amide
InChi Key
FEAZVKXLWFYRJK-UHFFFAOYSA-M
InChi Code
InChI=1S/C23H28ClN3O5S.Na/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18;/h7-12,15,18H,2-6,13-14H2,1H3,(H3,25,26,27,28,29);/q;+1/p-1
SMILES Code
COC1=CC=C(C=C1C(NCCC2=CC=C(S(=O)([N-]C(NC3CCCCC3)=O)=O)C=C2)=O)Cl.[Na+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
515.98
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Bircsak KM, Gupta V, Yuen PY, Gorczyca L, Weinberger BI, Vetrano AM, Aleksunes LM. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental BCRP Transporter. J Pharmacol Exp Ther. 2016 Feb 5. pii: jpet.115.230185. [Epub ahead of print] PubMed PMID: 26850786.
2: Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocrit Care. 2016 Feb;24(1):132-9. doi: 10.1007/s12028-015-0189-7. PubMed PMID: 26268138.
3: Harper LM, Glover AV, Biggio JR, Tita A. Predicting failure of glyburide therapy in gestational diabetes. J Perinatol. 2016 Jan 21. doi: 10.1038/jp.2015.216. [Epub ahead of print] PubMed PMID: 26796130.
4: Rezai S, Vielman M, Henderson CE. Glyburide vs Insulin and Adverse Pregnancy
Outcomes. JAMA Pediatr. 2015 Oct;169(10):974-5. doi:
10.1001/jamapediatrics.2015.1808. PubMed PMID: 26437012.
5: Tuccori M, Wu JW, Yin H, Majdan A, Azoulay L. The Use of Glyburide Compared
With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.
Diabetes Care. 2015 Nov;38(11):2083-9. doi: 10.2337/dc15-1358. Epub 2015 Sep 4.
PubMed PMID: 26341130.